Publications by authors named "L Akard"

Claim this Profile
I
Impact of Publicly Reported Outcomes on Patient Selection for Hematopoietic Cell Transplantation.
Christopher Strouse, Mark Juckett, Brent R Logan, Noel Estrada-Merly, Andrew Peterson, Luke P Akard

JCO Oncol Pract· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pemigatinib for Myeloid/Lymphoid Neoplasms with Rearrangement.
Srdan Verstovsek, Jean-Jacques Kiladjian, Alessandro M Vannucchi, Jay L Patel, Alessandro Rambaldi, Luke P Akard

NEJM Evid· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Public Reporting of Center-Specific Survival Analysis Scores on Patient Volumes at Hematopoietic Cell Transplant Centers.
Akshay Sharma, Brent Logan, Noel Estrada-Merly, Leslie E Lehmann, Hemalatha G Rangarajan, Luke P Akard

Transplant Cell Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Pinkal M Desai, Janice Brown, Saar Gill, Melham M Solh, Luke P Akard

J Clin Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation.
Johan Maertens, Aaron C Logan, Junho Jang, Gwynn Long, Jih-Luh Tang, Luke Akard

Antimicrob Agents Chemother· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis